Summary of Study ST000423
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000331. The data can be accessed directly via it's Project DOI: 10.21228/M80S3Z This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
Study ID | ST000423 |
Study Title | Differences in mycoplasma growth due to different mediums |
Study Summary | The object is to learn if there are variations in the lipid profiles of the three genomic variants (relative to one another) and if there are difference the lipid profiles due to growth in medium having different supplements. Mycoplasmas are eubacteria, but have only a single plasma membrane and no cell wall. They acquire FAs and cholesterol and other (perhaps many unknown) lipids from the medium which is complex and contains mammalian serum. Various mycoplasma species have been shown to contain a wide spectrum of bacterial lipids, but the composition is unknown for this mycoplasma species. We are particularly interested in ratios of membrane lipids among our strains, in part to gain clues about differences in metabolic pathways pertinent to membrane biogenesisÍž and to predict any underlying features that could relate to the extremely different modes of cell propagation observed among these genomic constructs. |
Institute | University of California, Davis |
Department | Genome and Biomedical Sciences Facility |
Laboratory | WCMC Metabolomics Core |
Last Name | Fiehn |
First Name | Oliver |
Address | 1315 Genome and Biomedical Sciences Facility, 451 Health Sciences Drive, Davis, CA 95616 |
ofiehn@ucdavis.edu | |
Phone | (530) 754-8258 |
Submit Date | 2016-07-08 |
Num Groups | 4 |
Total Subjects | 24 |
Raw Data Available | Yes |
Analysis Type Detail | LC-MS |
Release Date | 2016-09-23 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Treatment:
Treatment ID: | TR000458 |
Treatment Summary: | Different cell types: 1. Peritoneal macrophages 2. Bone marrow derived macrophages |
Treatment Protocol Filename: | StudyDesign-LauraQuigley-121214.pdf |